Clinical Trials Directory

Trials / Conditions / Alpha-1 Antitrypsin Deficiency (AATD)

Alpha-1 Antitrypsin Deficiency (AATD)

7 registered clinical trials studyying Alpha-1 Antitrypsin Deficiency (AATD) — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
NCT07227207
Tessera Therapeutics, Inc.Phase 1 / Phase 2
RecruitingScreening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
NCT07152834
Muğla Sıtkı Koçman University—
Active Not RecruitingStudy of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
NCT07193615
RenJi HospitalEARLY_Phase 1
CompletedEffect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency
NCT07242079
University of Parma—
CompletedA Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Particip
NCT06186492
Wave Life Sciences Ltd.Phase 1
CompletedAlvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
NCT03679598
University of Alabama at BirminghamPhase 2
CompletedSafety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
NCT01213043
Grifols Therapeutics LLCPhase 2